Global X Funds · 2019-04-05 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$4.4M | — | — | $76.8M | 每日估算 |
| 2026-07-30 | +$567,777 | — | — | $78.7M | 每日估算 |
| 2026-07-29 | -$741,293 | — | — | $78.4M | 每日估算 |
| 2026-07-28 | +$2.5M | — | — | $78.8M | 每日估算 |
| 2026-07-27 | +$1.3M | — | — | $76.8M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
MODERNA INC COMMON STOCK MODERNA INC COMMON STOCK | EC | 76,841 | $4.1M | 7.86% |
PRAXIS PRECISION MEDICINES I COMMON STOCK PRAXIS PRECISION MEDICINES I COMMON STOCK | EC | 9,697 | $3.3M | 6.23% |
ARROWHEAD PHARMACEUTICALS IN COMMON STOCK ARROWHEAD PHARMACEUTICALS IN COMMON STOCK | EC | 47,107 | $3.0M | 5.69% |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$2.1M | — | — | $76.8M | 每日估算 |
| 2026-07-25 | +$1.3M | — | — | $80.2M | 每日估算 |
| 2026-02-28 | -$1.9M | $0 | $1.9M | $52.4M | SEC 月度 |
| 2026-01-31 | -$1.9M | $0 | $1.9M | — | SEC 月度 |
| 2025-12-31 | $0 | $0 | $0 | — | SEC 月度 |
| EC |
| 19,973 |
| $2.7M |
| 5.13% |
GUARDANT HEALTH INC COMMON STOCK GUARDANT HEALTH INC COMMON STOCK | EC | 26,261 | $2.5M | 4.71% |
VERTEX PHARMACEUTICALS INC COMMON STOCK VERTEX PHARMACEUTICALS INC COMMON STOCK | EC | 4,551 | $2.3M | 4.32% |
BIOMARIN PHARMACEUTICAL INC COMMON STOCK BIOMARIN PHARMACEUTICAL INC COMMON STOCK | EC | 36,598 | $2.3M | 4.31% |
NATERA INC COMMON STOCK NATERA INC COMMON STOCK | EC | 9,843 | $2.0M | 3.91% |
BIONTECH SE-ADR DEPOSITARY RECEIPT BIONTECH SE-ADR DEPOSITARY RECEIPT | EC | 18,367 | $2.0M | 3.87% |
AVIDITY BIOSCIENCES INC COMMON STOCK AVIDITY BIOSCIENCES INC COMMON STOCK | EC | 27,249 | $2.0M | 3.75% |
QIAGEN N.V. COMMON STOCK QIAGEN N.V. COMMON STOCK | EC | 38,211 | $1.9M | 3.63% |
CRISPR THERAPEUTICS AG COMMON STOCK CRISPR THERAPEUTICS AG COMMON STOCK | EC | 30,338 | $1.8M | 3.48% |
BIO-TECHNE CORP COMMON STOCK BIO-TECHNE CORP COMMON STOCK | EC | 30,603 | $1.8M | 3.45% |
BRISTOL-MYERS SQUIBB CO COMMON STOCK BRISTOL-MYERS SQUIBB CO COMMON STOCK | EC | 22,278 | $1.4M | 2.65% |
ALNYLAM PHARMACEUTICALS INC COMMON STOCK ALNYLAM PHARMACEUTICALS INC COMMON STOCK | EC | 3,941 | $1.3M | 2.51% |
BNYREPOS BNYREPOS | RA | 1,252,576 | $1.3M | 2.39% |
VERACYTE INC COMMON STOCK VERACYTE INC COMMON STOCK | EC | 34,212 | $1.3M | 2.39% |
ELI LILLY & CO COMMON STOCK ELI LILLY & CO COMMON STOCK | EC | 1,165 | $1.2M | 2.34% |
TWIST BIOSCIENCE CORP COMMON STOCK TWIST BIOSCIENCE CORP COMMON STOCK | EC | 25,637 | $1.2M | 2.30% |
GILEAD SCIENCES INC COMMON STOCK GILEAD SCIENCES INC COMMON STOCK | EC | 8,009 | $1.2M | 2.28% |
ASTRAZENECA PLC COMMON STOCK ASTRAZENECA PLC COMMON STOCK | EC | 5,706 | $1.2M | 2.28% |
BEAM THERAPEUTICS INC COMMON STOCK BEAM THERAPEUTICS INC COMMON STOCK | EC | 40,627 | $1.2M | 2.21% |
10X GENOMICS INC-CLASS A COMMON STOCK 10X GENOMICS INC-CLASS A COMMON STOCK | EC | 49,124 | $1.1M | 2.16% |
LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT | EC | 59,071 | $1.1M | 2.14% |
ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK | EC | 39,779 | $930,431 | 1.78% |
GENEDX HOLDINGS CORP COMMON STOCK GENEDX HOLDINGS CORP COMMON STOCK | EC | 11,270 | $898,332 | 1.72% |
WAVE LIFE SCIENCES LTD COMMON STOCK WAVE LIFE SCIENCES LTD COMMON STOCK | EC | 56,445 | $786,279 | 1.50% |
GENSCRIPT BIOTECH CORP COMMON STOCK GENSCRIPT BIOTECH CORP COMMON STOCK | EC | 498,918 | $761,566 | 1.45% |
SAREPTA THERAPEUTICS INC COMMON STOCK SAREPTA THERAPEUTICS INC COMMON STOCK | EC | 40,976 | $686,758 | 1.31% |
INTELLIA THERAPEUTICS INC COMMON STOCK INTELLIA THERAPEUTICS INC COMMON STOCK | EC | 45,069 | $621,051 | 1.19% |
CAREDX INC COMMON STOCK CAREDX INC COMMON STOCK | EC | 22,308 | $418,498 | 0.80% |
UNIQURE NV COMMON STOCK UNIQURE NV COMMON STOCK | EC | 24,242 | $378,902 | 0.72% |
VIR BIOTECHNOLOGY INC COMMON STOCK VIR BIOTECHNOLOGY INC COMMON STOCK | EC | 40,138 | $364,854 | 0.70% |
PERSONALIS INC COMMON STOCK PERSONALIS INC COMMON STOCK | EC | 23,562 | $213,472 | 0.41% |
PACIFIC BIOSCIENCES OF CALIF COMMON STOCK PACIFIC BIOSCIENCES OF CALIF COMMON STOCK | EC | 119,496 | $200,753 | 0.38% |
AGILENT TECHNOLOGIES INC COMMON STOCK AGILENT TECHNOLOGIES INC COMMON STOCK | EC | 1,653 | $200,641 | 0.38% |
ROCKET PHARMACEUTICALS INC COMMON STOCK ROCKET PHARMACEUTICALS INC COMMON STOCK | EC | 37,567 | $188,211 | 0.36% |
PRIME MEDICINE INC COMMON STOCK PRIME MEDICINE INC COMMON STOCK | EC | 40,671 | $187,900 | 0.36% |
REGENXBIO INC COMMON STOCK REGENXBIO INC COMMON STOCK | EC | 20,483 | $185,166 | 0.35% |
MYRIAD GENETICS INC COMMON STOCK MYRIAD GENETICS INC COMMON STOCK | EC | 39,242 | $180,906 | 0.35% |
MESA LABORATORIES INC COMMON STOCK MESA LABORATORIES INC COMMON STOCK | EC | 1,851 | $178,751 | 0.34% |
MARAVAI LIFESCIENCES HLDGS-A COMMON STOCK MARAVAI LIFESCIENCES HLDGS-A COMMON STOCK | EC | 46,674 | $166,159 | 0.32% |
STOKE THERAPEUTICS INC COMMON STOCK STOKE THERAPEUTICS INC COMMON STOCK | EC | 4,522 | $164,646 | 0.31% |
STANDARD BIOTOOLS INC COMMON STOCK STANDARD BIOTOOLS INC COMMON STOCK | EC | 119,323 | $134,835 | 0.26% |
FULGENT GENETICS INC COMMON STOCK FULGENT GENETICS INC COMMON STOCK | EC | 8,763 | $134,337 | 0.26% |
ARCTURUS THERAPEUTICS HOLDIN COMMON STOCK ARCTURUS THERAPEUTICS HOLDIN COMMON STOCK | EC | 15,040 | $123,779 | 0.24% |
CARIBOU BIOSCIENCES INC COMMON STOCK CARIBOU BIOSCIENCES INC COMMON STOCK | EC | 59,913 | $113,835 | 0.22% |
SANA BIOTECHNOLOGY INC COMMON STOCK SANA BIOTECHNOLOGY INC COMMON STOCK | EC | 26,441 | $111,317 | 0.21% |
SANGAMO THERAPEUTICS INC COMMON STOCK SANGAMO THERAPEUTICS INC COMMON STOCK | EC | 244,820 | $105,836 | 0.20% |
EDITAS MEDICINE INC COMMON STOCK EDITAS MEDICINE INC COMMON STOCK | EC | 46,709 | $102,760 | 0.20% |
ATRIUM THERAPEUTICS INC COMMON STOCK ATRIUM THERAPEUTICS INC COMMON STOCK | EC | 2,725 | $40,192 | 0.08% |